Kodiak Sciences News and Activities

Kodiak Sciences is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Kodiak Sciences is a company listed under the stock ticker KOD (US).

View the org chart displaying its 18 main executives

Most searched biographies at Kodiak Sciences

• Victor Perlroth, Chairman and Chief Executive Officer
• Taiyin Yang, Director
• Charles Bancroft, Director

Create your alert
to follow the executive moves at Kodiak Sciences.

Kodiak Sciences has 2,417 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Zymeworks has announced the acquisition of Theravance Biopharma  (posted on June 29 2026).
• Tissium has just announced a $68 Million fundraising (posted on June 29 2026).
• Oblenio Bio has just announced a $62 Million fundraising (posted on June 26 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Kodiak Sciences

• Kodiak Sciences Treats First Patients in Three Phase 3 Studies of KSI-301 - Two Studies in Diabetic Macular Edema and One Study in Macular Edema Due to Retinal Vein Occlusion | Kodiak Sciences Inc.
• Kodiak Sciences to Present at Upcoming Conferences | Kodiak Sciences Inc.
• Kodiak Sciences Announces Second Quarter 2020 Financial Results and Recent Business Highlights | Kodiak Sciences Inc.
• Lonza's Ibex Dedicate to Support the Commercial Manufacture of Kodiak’s KSI-301 - an Antibody Biopolymer Conjugate for Retinal Diseases | Kodiak Sciences Inc.
• Kodiak Sciences to Host R&D Webcast to Review Recent Data from the Ongoing Phase 1b Study of KSI-301 and Highlight KSI-301 Clinical Development Progress | Kodiak Sciences Inc.
• Kodiak Sciences Announces New Longer-Term Safety, Efficacy and Durability Data from Ongoing Phase 1b Study of KSI-301 in Patients with Wet Age-Related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion at the American Society of Retin
• Kodiak Sciences Announces Upcoming Presentation of KSI-301 Clinical Study Data at American Society of Retina Specialists (ASRS) 2020 Virtual Annual Meeting and R&D Webinar | Kodiak Sciences Inc.
• Kodiak Sciences to Present at Upcoming Conferences | Kodiak Sciences Inc.
• Kodiak Sciences to Present at the Bank of America Merrill Lynch Health Care Conference | Kodiak Sciences Inc.
• Kodiak Sciences Announces First Quarter 2020 Financial Results and Recent Business Highlights | Kodiak Sciences Inc.
• View more press releases Close

Social media about Kodiak Sciences

• Kodiak Sciences on Wikipedia, Google News & Yahoo Finance
• Kodiak Sciences on LinkedIn, X (Twitter) & YouTube